Xu Z - Search Results

1

A SOX9-AS1/miR-5590-3p/SOX9 positive feedback loop drives tumor growth and metastasis in hepatocellular carcinoma through the Wnt/β-catenin pathway.

Zhang W, Wu Y, Hou B, Wang Y, Deng D, Fu Z, Xu Z. Zhang W, et al. Among authors: xu z. Mol Oncol. 2019 Oct;13(10):2194-2210. doi: 10.1002/1878-0261.12560. Epub 2019 Aug 31. Mol Oncol. 2019. PMID: 31402556 Free PMC article.

2

Role of hypoxia-inducible-1α in hepatocellular carcinoma cells using a Tet-on inducible system to regulate its expression in vitro.

Xu Z, Liu E, Peng C, Li Y, He Z, Zhao C, Niu J. Xu Z, et al. Oncol Rep. 2012 Feb;27(2):573-8. doi: 10.3892/or.2011.1533. Epub 2011 Nov 8. Oncol Rep. 2012. PMID: 22075557

3

Hypoxia-inducible factor-1alpha suppressed hepatocellular carcinoma cell apoptosis through influencing on Omi/HtrA2 expression and its releasing from the mitochondrion.

Xu Z, Chen X, Peng C, Liu E, Li Y, Li C, Niu J. Xu Z, et al. Oncol Res. 2012;20(5-6):213-20. doi: 10.3727/096504013x13589503482815. Oncol Res. 2012. PMID: 23581228

4

Clinical and pathological features and surgical treatment of Budd-Chiari syndrome-associated hepatocellular carcinoma.

Wang YD, Xue HZ, Zhang X, Xu ZQ, Jiang QF, Shen Q, Yu M, Li K, Jia M. Wang YD, et al. Chin Med J (Engl). 2013;126(19):3632-8. Chin Med J (Engl). 2013. PMID: 24112155

5

Omi/HtrA2 pro-apoptotic marker differs in various hepatocellular carcinoma cell lines owing to ped/pea-15 expression level.

Xu Z, Chen Y, Xu G, Peng C, Liu E, Li Y, Niu J, Li C. Xu Z, et al. Among authors: xu g. Oncol Rep. 2015 Feb;33(2):905-12. doi: 10.3892/or.2014.3656. Epub 2014 Dec 8. Oncol Rep. 2015. PMID: 25484138

6

Screening of significant biomarkers related with prognosis of liver cancer by lncRNA-associated ceRNAs analysis.

He J, Zhao H, Deng D, Wang Y, Zhang X, Zhao H, Xu Z. He J, et al. Among authors: xu z. J Cell Physiol. 2020 Mar;235(3):2464-2477. doi: 10.1002/jcp.29151. Epub 2019 Sep 10. J Cell Physiol. 2020. PMID: 31502679

7

[Expression of Twist gene in human hepatocellular carcinoma and its clinicopathological significance].

Li CH, Chen XP, Xu ZQ, Li GP, Guan J. Li CH, et al. Zhonghua Wai Ke Za Zhi. 2006 Oct 1;44(19):1353-6. Zhonghua Wai Ke Za Zhi. 2006. PMID: 17217825 Chinese.

8

The roles of four multi-drug resistance proteins in hepatocellular carcinoma multidrug resistance.

Li G, Chen X, Wang Q, Xu Z, Zhang W, Ye L. Li G, et al. Among authors: xu z. J Huazhong Univ Sci Technolog Med Sci. 2007 Apr;27(2):173-5. doi: 10.1007/s11596-007-0217-8. J Huazhong Univ Sci Technolog Med Sci. 2007. PMID: 17497289

9

[Inducible expression of hypoxia-inducible factor 1alpha on the proliferation and invasion property of HepG2 cells under normoxia in vitro].

Jin WD, Chen XP, Yang SL, Xu ZQ, Zhang WG. Jin WD, et al. Zhonghua Wai Ke Za Zhi. 2007 Dec 1;45(23):1634-6. Zhonghua Wai Ke Za Zhi. 2007. PMID: 18453222 Chinese.

10

[The prognostic significance of Omi/HtrA2 expression, and correlation between Omi/HtrA2 and hypoxia-inducible factor-1α in primary hepatocellular carcinoma cells].

Xu ZQ, Chen XP, Niu J, Liu EY, Li CH, Peng C. Xu ZQ, et al. Zhonghua Wai Ke Za Zhi. 2012 Jan 1;50(1):49-52. Zhonghua Wai Ke Za Zhi. 2012. PMID: 22490291 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39,275 results

Search Page

Filters